Skip to main content
Journal cover image

IT-34 * PILOT STUDY OF COMBINATION OF ANTITUMOR IMMUNOTHERAPY TARGETED AGAINST CYTOMEGALOVIRUS (CMV) PLUS REGULATORY T-CELL INHIBITION IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM)

Publication ,  Journal Article
Vlahovic, G; Archer, G; Lally-Goss, D; Reap, E; Batich, K; Desjardins, A; Peters, K; Ranjan, T; Healy, P; Herndon, J; Friedman, A; Friedman, H ...
Published in: Neuro-Oncology
November 1, 2014

Duke Scholars

Published In

Neuro-Oncology

DOI

EISSN

1523-5866

ISSN

1522-8517

Publication Date

November 1, 2014

Volume

16

Issue

suppl 5

Start / End Page

v117 / v117

Publisher

Oxford University Press (OUP)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Vlahovic, G., Archer, G., Lally-Goss, D., Reap, E., Batich, K., Desjardins, A., … Sampson, J. (2014). IT-34 * PILOT STUDY OF COMBINATION OF ANTITUMOR IMMUNOTHERAPY TARGETED AGAINST CYTOMEGALOVIRUS (CMV) PLUS REGULATORY T-CELL INHIBITION IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM). Neuro-Oncology, 16(suppl 5), v117–v117. https://doi.org/10.1093/neuonc/nou258.32
Vlahovic, G., G. Archer, D. Lally-Goss, E. Reap, K. Batich, A. Desjardins, K. Peters, et al. “IT-34 * PILOT STUDY OF COMBINATION OF ANTITUMOR IMMUNOTHERAPY TARGETED AGAINST CYTOMEGALOVIRUS (CMV) PLUS REGULATORY T-CELL INHIBITION IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM).” Neuro-Oncology 16, no. suppl 5 (November 1, 2014): v117–v117. https://doi.org/10.1093/neuonc/nou258.32.
Vlahovic, G., et al. “IT-34 * PILOT STUDY OF COMBINATION OF ANTITUMOR IMMUNOTHERAPY TARGETED AGAINST CYTOMEGALOVIRUS (CMV) PLUS REGULATORY T-CELL INHIBITION IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM).” Neuro-Oncology, vol. 16, no. suppl 5, Oxford University Press (OUP), Nov. 2014, pp. v117–v117. Crossref, doi:10.1093/neuonc/nou258.32.
Vlahovic G, Archer G, Lally-Goss D, Reap E, Batich K, Desjardins A, Peters K, Ranjan T, Healy P, Herndon J, Friedman A, Friedman H, Bigner D, Sampson J. IT-34 * PILOT STUDY OF COMBINATION OF ANTITUMOR IMMUNOTHERAPY TARGETED AGAINST CYTOMEGALOVIRUS (CMV) PLUS REGULATORY T-CELL INHIBITION IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM). Neuro-Oncology. Oxford University Press (OUP); 2014 Nov 1;16(suppl 5):v117–v117.
Journal cover image

Published In

Neuro-Oncology

DOI

EISSN

1523-5866

ISSN

1522-8517

Publication Date

November 1, 2014

Volume

16

Issue

suppl 5

Start / End Page

v117 / v117

Publisher

Oxford University Press (OUP)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences